investig
potenti
rna
interfer
rnai
antivir
agent
rabi
two
small
interf
rna
sirna
target
rabi
viru
rabv
nucleoprotein
n
polymeras
l
gene
design
evalu
sirna
knockdown
silenc
target
rabv
gene
evalu
plasmid
base
transient
express
model
effici
deliveri
adenovirus
express
sirna
construct
antivir
potenti
deliv
sirna
investig
cell
cell
treat
adenovirus
express
sirna
challeng
rabv
reduct
rabv
multipl
infect
cell
sirna
target
rabvn
l
gene
respect
rel
quantif
rabv
transcript
use
realtim
pcr
reveal
knockdown
rabvn
l
gene
transcript
howev
signific
reduct
observ
adenoviru
express
sirna
rabvn
mice
treat
intracerebr
adenovirus
express
sirna
challeng
peripher
lethal
rabv
intramuscular
rout
masset
muscl
protect
adenovirus
express
sirna
rabvn
l
gene
respect
result
demonstr
adenoviru
express
sirna
rabvn
effici
inhibit
rabv
multipl
vitro
vivo
confer
signific
protect
lethal
rabv
challeng
support
hypothesi
rnai
base
sirna
target
rabvn
gene
prevent
rabv
infect
hold
potenti
rnai
approach
prevent
rabi
infect
rabi
dread
diseas
caus
viru
belong
genu
lyssaviru
famili
rhabdovirida
rabi
viru
rabv
infect
consid
one
oldest
fatal
neurolog
diseas
known
mankind
present
practic
rabi
control
anim
human
take
prophylact
preexposur
vaccin
postexposur
vaccin
obligatori
case
treatment
human
exposur
infect
anim
bite
wiktor
abbrevi
ad
adenoviru
babi
hamster
cn
central
nervou
system
challeng
viru
egfp
enhanc
green
fluoresc
protein
ffu
fluoresc
foci
unit
human
embryon
l
larg
polymeras
lethal
dose
moi
multipl
infect
n
nucleoprotein
pasteur
rfp
red
fluoresc
protein
rnai
rna
interfer
rabv
rabi
viru
shrna
small
hairpin
rna
sirna
small
interf
rna
correspond
author
tel
fax
email
address
praveenindian
gmailcom
pk
gupta
et
al
sometim
due
unnot
exposur
vaccin
failur
diseas
diagnos
onset
clinic
symptom
death
becom
unavoid
due
unavail
effect
line
treatment
clinic
case
rabi
therefor
effort
made
develop
effect
antivir
strategi
rabi
potenti
suppress
viru
infect
cell
clear
infect
without
damag
cell
variou
approach
includ
strategi
base
rna
interfer
rnai
consid
potenti
rnai
antivir
agent
group
evalu
rnai
base
antivir
agent
rabi
brandao
et
al
israsena
et
al
rnai
mediat
small
interf
rna
sirna
power
technolog
allow
silenc
gene
great
specif
potenc
highli
conserv
natur
mechan
describ
plant
fungi
worm
insect
mammal
et
al
review
gene
silenc
mechan
mediat
short
rna
name
sirna
wherebi
rnainduc
silenc
complex
form
activ
complex
target
mrna
sequenc
complementari
sirna
render
mrna
transcript
inert
degrad
result
specif
knockdown
target
gene
express
sequencespecif
knockdown
viral
gene
infect
cell
gener
great
interest
develop
sirnasbas
antivir
agent
sirnabas
antivir
activ
report
mani
rna
dna
virus
vitro
vivo
includ
human
immunodefici
viru
polioviru
hepat
b
viru
hepat
c
viru
human
papilloma
viru
dengu
viru
hepat
delta
viru
murin
gamma
herpesvirus
sever
acut
coronaviru
respiratori
syncyti
viru
infect
sliva
schnierl
review
present
studi
report
sirnabas
rnai
inhibit
rabv
multipl
sirna
target
rabvn
l
gene
design
deliv
use
adenovir
vector
inhibit
rabv
multipl
evalu
vitro
cell
protect
lethal
rabv
challeng
evalu
vivo
mice
intracerebr
treatment
adenovirus
express
sirna
target
rabv
gene
babi
hamster
human
embryon
cell
use
studi
procur
nation
centr
cell
scienc
ncc
pune
india
grown
c
co
dulbecco
modifi
minimum
essenti
medium
dmem
hyclon
supplement
fetal
bovin
serum
fb
hyclon
gml
gentamicin
mous
brainadapt
rabv
challeng
viru
strain
use
amplifi
rabv
gene
rtpcr
vivo
challeng
mice
rabv
pasteur
strain
adapt
use
vitro
challeng
studi
cell
target
gene
report
plasmid
pdsredn
pdsredl
construct
express
rabvn
l
protein
respect
ctermin
fusion
red
fluoresc
protein
rfp
construct
pdsredn
fulllength
bp
rabvn
gene
amplifi
rtpcr
primer
supplementari
tabl
use
cdna
prepar
total
rna
isol
mous
brain
insert
hindiii
bamhi
site
vector
clontech
similarli
pdsredl
construct
amplifi
bp
partial
rabvl
polymeras
gene
fragment
contain
sirna
target
site
rtpcr
use
primer
supplementari
tabl
clone
xhoi
bamhi
site
vector
express
red
fluoresc
protein
rfp
fusion
protein
nrfp
lrfp
confirm
transfect
cell
sirna
target
rabvn
l
gene
design
use
algorithm
follow
sequencemotif
thermodynam
guidelin
uitei
et
al
two
sirna
sequenc
sin
sil
along
antisens
loop
sequenc
synthes
oligonucleotid
supplementari
tabl
anneal
clone
shrna
express
plasmid
pmcsegfpcontain
enhanc
green
fluoresc
protein
egfp
report
gene
one
scrambl
sirna
sic
homolog
rabv
genom
also
clone
shrna
neg
control
sirna
supplementari
tabl
evalu
effici
sirna
silenc
rabv
gene
cell
transient
cotransfect
two
plasmid
report
gene
construct
encod
either
rabvn
l
gene
fuse
rfp
silenc
construct
encod
genespecif
sirna
sin
sil
neg
control
sirna
sic
cell
cotransfect
use
lipofectomin
reagent
invitrogen
plate
analyz
rfp
egfp
express
h
posttransfect
use
olympu
fluoresc
microscop
cell
egfp
express
indic
express
shrna
cell
rfp
express
indic
rabvn
l
target
report
gene
express
cell
appar
absenc
red
fluoresc
indic
gene
silenc
recombin
adenovirus
express
differ
sirna
sin
sil
sic
construct
use
psilenc
adeno
system
ambion
briefli
sens
antisens
oligonucleotid
cohes
restrict
endonucleas
site
end
supplementari
tabl
anneal
clone
adeno
shuttl
vector
recombin
adeno
shuttl
vector
cotransfect
linear
adenoviru
lacz
backbon
plasmid
cell
recombin
adenoviru
produc
vitro
vivo
studi
differ
recombin
adenovirus
name
adn
adl
adneg
expand
cell
purifi
use
adeasi
viru
purif
kit
stratagen
purifi
adenoviru
infecti
unit
titer
determin
cell
tenfold
limit
dilut
xgal
stain
follow
manufactur
instruct
ambion
character
recombin
adenovirus
viral
genom
dna
adn
adl
adneg
isol
use
qiaamp
dna
mini
kit
qiagen
bp
fragment
contain
shrna
sequenc
amplifi
pcr
use
primer
psiadenof
r
supplementari
tabl
sequenc
verifi
integr
sirna
analyz
antirabi
effect
differ
sirna
vitro
sirna
deliv
cell
treat
recombin
adenovirus
briefli
cell
infect
multipl
infect
moi
differ
adenovirus
presenc
polybren
gml
h
h
treatment
transduct
effici
analyz
xgal
stain
effici
differ
sirna
inhibit
rabv
multipl
evalu
adenovirustr
cell
vitro
challeng
briefli
cell
infect
differ
adenovirus
plate
h
infect
moi
h
postadsorpt
unadsorb
rabv
inoculum
remov
infect
cell
monolay
wash
three
time
pb
h
postinfect
infect
cell
cultur
supernat
harvest
store
c
viru
titer
determin
infect
cell
monolay
fix
aceton
rabv
infect
cell
detect
direct
fluoresc
antibodi
stain
use
rabi
antinucleocapsid
fitclabel
antibodi
biorad
follow
manufactur
instruct
cell
monolay
nuclear
counterstain
prolong
gold
antifad
reagent
dapi
invitrogen
rabv
titer
infect
cell
cultur
supernat
determin
fluoresc
foci
unit
ffu
assay
briefli
serial
dilut
viru
supernat
harvest
h
postinfect
mix
cell
flatbottom
plate
triplic
incub
c
two
day
infect
infect
cell
fix
aceton
plaqu
visual
stain
rabi
antinucleocapsid
fitclabel
antibodi
ffu
titer
determin
evalu
effici
differ
sirna
silenc
express
target
rabv
gene
quantit
determin
rabv
mrna
done
use
realtim
pcr
differ
adenovirustr
cell
plate
infect
moi
h
postinfect
total
rna
isol
use
trizol
ls
reagent
invitrogen
mrna
transcript
total
rna
revers
transcrib
cdna
use
oligo
dt
primer
revertaid
mmulv
revers
transcriptas
fermenta
follow
manufactur
protocol
rabvn
l
gene
transcript
dilut
cdna
quantifi
use
gene
specif
realtim
primer
supplementari
tabl
use
kapa
sybr
fast
qpcr
kit
kapa
biosystem
follow
manufactur
instruct
rel
quantif
gapdh
gene
transcript
use
refer
gene
express
normal
nfold
chang
target
mrna
transcript
level
determin
use
method
describ
earlier
pfaffl
swiss
albino
mice
week
old
either
sex
group
four
group
twelv
mice
three
group
mice
n
inject
intracerebr
infecti
adenoviru
particl
either
adn
adl
adneg
l
volum
one
group
mice
n
inject
salin
kept
neg
control
group
mice
challeng
intramuscular
rout
masset
muscl
ld
lethal
l
volum
follow
method
nih
test
potenc
wilbur
aubert
challeng
mice
observ
day
develop
rabiesspecif
paralyt
symptom
death
percent
surviv
calcul
rabv
titer
gene
transcript
compar
statist
analysi
use
oneway
anova
follow
dunnett
test
treatment
versu
control
comparison
surviv
done
logrank
test
follow
mantelhaenszel
method
use
graphpad
prism
version
graphpad
data
present
mean
sem
differ
group
p
consid
statist
signific
two
differ
sirna
target
rabvn
mrna
nt
l
mrna
nt
design
sequenc
clone
shrna
express
plasmid
pmcsegfp
gener
silenc
construct
express
sirna
rabvn
l
gene
sinc
pmcsegfp
plasmid
also
includ
egfp
report
gene
easi
identifi
cell
shrna
express
plasmid
first
examin
whether
sirna
could
specif
knockdown
silenc
express
correspond
rabvn
l
protein
cell
transient
cotransfect
target
report
gene
plasmid
pdsredn
pdsredl
sirna
express
plasmid
rfptag
version
rabvn
l
protein
nrfp
lrfp
detect
transfect
cell
cell
contain
target
report
gene
plasmid
specif
sirna
silenc
construct
corrobor
reduct
rfp
express
indic
reduct
target
report
gene
express
compar
control
cotransfect
neg
control
sirna
express
plasmid
fig
confirm
express
sirna
effect
silenc
target
gene
genespecif
manner
order
develop
adenovir
sirna
deliveri
system
sirna
sequenc
shrna
form
clone
adeno
shuttl
vector
insert
genom
adenoviru
defect
earli
gene
integr
sirna
sequenc
recombin
adenovirus
adn
adl
adneg
confirm
amplifi
bp
dna
fragment
flank
shrna
genom
dna
isol
differ
recombin
adenovirus
nucleotid
sequenc
determin
supplementari
fig
infect
titer
purifi
recombin
adenovirus
adn
adl
adneg
estim
cell
xgal
stain
found
per
ml
respect
sinc
adenoviru
backbon
contain
lacz
gene
infect
cell
activ
gave
blue
plaqu
xgal
stain
supplementari
fig
analyz
antivir
effect
sirna
cell
deliv
adenovir
vector
necessari
determin
amount
recombin
adenoviru
need
yield
highest
level
sirna
express
without
cellular
toxic
cell
treat
differ
moi
adenovirus
presenc
absenc
polybren
result
shown
found
treatment
cell
moi
adenoviru
presenc
polybren
gml
suffici
transduc
high
proport
cell
without
toxic
supplementari
fig
assess
effect
sirna
deliv
recombin
adenovirus
inhibit
rabv
multipl
adenovirustr
cell
infect
h
postinfect
rabv
multipl
analyz
infect
cell
monolay
cellassoci
viru
infect
cell
cultur
supernat
cellreleas
viru
presenc
rabv
evid
fluoresc
foci
stain
reveal
reduct
rabv
multipl
sirna
compar
control
sirna
fig
reduct
adn
adenoviru
express
sirna
rabvn
pronounc
compar
adl
estim
inhibitori
effect
sirna
rabv
multipl
precis
abil
limit
infecti
viru
product
analyz
rabv
ffu
count
infect
cell
cultur
supernat
adnand
adltreat
cell
show
ffuml
rabv
respect
adnegtr
cell
show
ffuml
rabv
result
averag
four
independ
experi
collect
signific
reduct
rabv
ffu
count
adn
express
sirna
rabvn
reduct
howev
nonsignific
adl
express
sirna
rabvl
fig
result
clearli
indic
h
postchalleng
presenc
rabv
infect
cell
detect
stain
antirabi
nucleocapsid
fitclabel
antibodi
counterstain
dapi
stain
cell
observ
fluoresc
microscop
repres
fluorescentfield
imag
fitc
filter
left
column
rel
nuclear
stainedfield
imag
dapi
filter
right
column
record
sirna
name
sin
sil
deliv
use
adenovir
vector
could
inhibit
rabv
multipl
cell
inhibitori
effect
pronounc
higher
sin
compar
sil
assess
abil
sirna
knockdown
express
rabv
gene
rel
level
rabvn
l
transcript
differ
adenovirustr
rabvinfect
cell
quantifi
realtim
pcr
normal
use
gapdh
housekeep
gene
analyz
result
six
independ
experi
demonstr
rabvn
l
transcript
significantli
decreas
cell
treat
adn
compar
control
effect
less
pronounc
reduct
transcript
cellstreat
adl
fig
indic
adenovirus
adl
adn
effect
deliv
sirna
cell
caus
reduct
level
target
mrna
transcript
howev
effect
signific
adn
express
sirna
rabvn
assess
whether
sirna
could
inhibit
rabv
multipl
vivo
use
establish
murin
model
rabv
infect
differ
adenoviru
treat
mice
challeng
ld
lethal
rabv
intramuscular
rout
masset
muscl
percent
protect
determin
control
mice
mice
treat
adenoviru
express
control
sirna
develop
rabiesspecif
symptom
die
within
day
postchalleng
median
surviv
day
respect
median
surviv
increas
day
protect
group
mice
treat
adl
adenoviru
express
sirna
rabvl
treatment
mice
adn
adenoviru
express
sirna
rabvn
demonstr
protect
fig
mice
surviv
develop
symptom
remain
healthi
till
entir
period
experiment
result
indic
treatment
mice
adenoviru
express
fig
inhibit
rabv
product
cell
treat
differ
adenovirus
express
sirna
cell
first
treat
differ
adenovirus
express
sirna
infect
moi
strain
infect
cell
cultur
supernat
harvest
h
postinfect
rabv
titer
measur
rabi
fluoresc
foci
unit
ffu
assay
data
shown
mean
sem
four
independ
experi
group
differ
rabv
titer
comparison
control
adneg
p
oneway
anova
dunnett
method
rel
level
rabvn
l
transcript
differ
adenovirustr
cell
quantifi
realtim
pcr
cell
first
treat
differ
adenovirus
express
sirna
infect
strain
moi
h
postinfect
total
rna
isol
infect
cell
transcrib
cdna
use
oligodt
primer
rabvn
l
gene
transcript
cdna
quantifi
use
genespecif
primer
realtim
pcr
gapdh
gene
transcript
use
refer
normal
data
present
six
independ
experi
nfold
chang
target
mrna
transcript
level
determin
oneway
anova
statist
analysi
data
follow
comparison
control
use
dunnett
method
sirna
rabvl
confer
modest
protect
lethal
rabi
challeng
protect
increas
significantli
mice
treat
adenoviru
express
sirna
rabvn
gene
indic
effect
sin
sil
rabi
vivo
rabv
introduc
broken
skin
mucou
membran
replic
myocyt
hour
week
migrat
nerv
fekadu
shaddock
murphi
develop
infect
spinal
cord
brain
stem
neuron
rabv
dissemin
rapidli
throughout
central
nervou
system
cn
fast
axon
transport
along
neuroanatom
connect
mice
n
per
group
treat
intracerebr
differ
adenovirus
adn
adl
adneg
control
salin
challeng
intramuscular
rout
masset
muscl
lethal
strain
percent
surviv
postchalleng
monitor
adntreat
mice
group
differ
control
adnegtr
surviv
p
logrank
natur
condit
rabv
infect
cn
caus
rel
mild
neuropatholog
chang
without
promin
evid
neuron
death
iwasaki
tobita
altogeth
observ
led
concept
neurolog
diseas
rabi
result
neuron
dysfunct
rather
neuron
cell
death
fact
strategi
develop
inhibit
rabv
multipl
cn
block
pathogen
process
rabi
therefor
diseas
progress
develop
may
prevent
infect
individu
rabv
approxim
kb
long
singlestrand
rna
genom
consist
nucleotid
long
leader
follow
nucleoprotein
n
phosphoprotein
p
matrix
glycoprotein
g
larg
polymeras
l
gene
encod
protein
name
n
p
g
l
report
vitro
evalu
rnai
rabi
target
viral
structur
gene
like
n
g
israsena
et
al
target
n
gene
found
effect
rabvg
remain
unsuccess
target
rnai
rabvg
consid
nonessenti
viru
replic
vitro
cultur
cell
requir
transsynapt
viral
spread
neuron
vivo
etessami
et
al
yan
et
al
modifi
rabvg
use
deliv
sirna
across
bloodbrain
barrier
kumar
et
al
target
rnai
rabi
nonstructur
gene
like
p
israsena
et
al
l
brandao
et
al
limit
antivir
potenti
design
sirna
remain
effect
requir
region
viral
genom
conserv
among
differ
strain
viru
consequ
select
rabvn
l
target
gene
design
sirna
conserv
essenti
viru
multipl
moreov
select
sirna
conserv
region
rabv
genom
potenti
region
secondari
structur
format
consid
use
sirna
design
algorithm
sinc
screen
effect
sirna
infecti
virus
tediou
timeconsum
requir
intens
safeti
condit
simpl
method
screen
potent
sirna
use
present
studi
demonstr
transient
cotransfect
report
gene
construct
silenc
construct
appropri
method
screen
potent
sirna
induc
cleavag
mrna
fuse
red
fluoresc
protein
rfp
report
genespecif
sirna
provid
simpl
model
assess
sirna
effici
gene
silenc
analysi
reduc
express
fusion
protein
express
fluoresc
microscop
sin
sil
consist
inhibit
express
rfp
fusion
version
rabvn
l
protein
three
independ
experi
indic
potent
sirna
studi
screen
effect
sirna
use
transient
cotransfect
plasmid
report
previous
target
rabv
gene
sanchez
et
al
meng
et
al
ong
et
al
deliveri
sirna
remain
signific
obstacl
develop
sirnabas
therapeut
differ
approach
use
effici
deliv
sirna
neuron
tissu
includ
use
nonvir
posada
et
al
review
viral
vector
sliva
schnierl
review
vivo
deliveri
sirna
rabi
technolog
requir
could
deliv
rnai
therapeut
neuron
cell
adenoviru
lentiviru
base
viral
vector
carri
precis
task
becom
major
deliveri
system
sirna
nerv
tissu
sliva
schnierl
first
studi
employ
adenovir
vector
vivo
rnai
publish
applic
central
nervou
system
xia
et
al
studi
also
select
adenoviru
vector
system
deliv
sirna
brain
cell
effici
differ
sirna
deliv
recombin
adenovirus
analyz
cell
challeng
sinc
strain
adapt
cell
serv
model
analyz
effici
sirna
vitro
rnai
function
identifi
degrad
mrna
share
sequenc
complementar
sirna
therefor
realtim
pcr
analysi
use
analyz
effect
sin
sil
rabvn
l
mrna
express
respect
level
rabvn
mrna
adntreat
rabvinfect
cell
significantli
reduc
compar
adltreat
cell
gapdh
use
cellular
mrna
control
show
effect
sirna
treatment
level
rabvl
mrna
adntreat
cell
also
reduc
indic
interrel
effect
may
due
fact
rabvn
perform
effect
rabv
multipl
two
way
rabvn
major
structur
protein
also
play
regulatori
role
switch
gene
express
mrna
product
genom
replic
intracellular
ratio
leader
rna
n
protein
report
regul
switch
viral
gene
transcript
genom
replic
wunner
confirm
antivir
potenti
rabvnspecif
sirna
monitor
presenc
viral
progeni
supernat
sirnatreatedrabv
infect
cell
level
folddecreas
rabvn
express
correl
decreas
infect
viru
titer
adn
treat
cell
decreas
infect
rabv
titer
adntreat
cell
compar
adltreat
cell
effici
sirna
also
analyz
inhibit
rabv
multipl
vivo
mice
protect
efficaci
differ
sirna
lethal
rabv
challeng
evalu
inject
recombin
adenovirus
carri
appropri
sirna
intracerebr
mice
challeng
mous
adapt
strain
mice
treat
adn
show
maximum
inhibitori
effect
rabv
multipl
vitro
cell
also
demonstr
significantli
high
protect
contrast
mice
treat
adl
less
effect
vitro
moder
protect
control
sirnaexpress
adenoviru
could
demonstr
protect
indic
lethal
natur
challeng
viru
recent
studi
also
indic
short
rabvn
cdna
artifici
microrna
could
interfer
rabv
replic
cell
wunner
et
al
israsena
et
al
synthet
sirna
rabvn
could
reduc
rabv
multipl
cell
brandao
et
al
intracrani
inject
sirna
mice
shown
immens
potenti
suppress
enceph
caus
chandipura
viru
belong
famili
rhabdovirida
kumar
arankal
two
flavivirus
jev
japanes
enceph
viru
wnv
west
nile
viru
kumar
et
al
basi
result
report
conclud
sirna
rabvn
could
knockdown
express
rabv
mrna
subsequ
inhibit
rabv
product
effici
ii
inhibitori
effect
sirna
rabvn
interfer
viral
gene
express
significantli
increas
protect
lethal
rabv
challeng
find
signific
implic
use
sirna
therapeut
agent
rabv
infect
howev
attain
absolut
protect
sirna
deliveri
method
eg
lentivir
rout
intraven
cross
bloodbrain
barrier
dose
singl
multipl
sirna
time
therapeut
administr
sirna
care
optim
mice
nonhuman
primat
recommend
therapeut
use
